tiprankstipranks
Flora Growth Hails DEA’s Cannabis Rescheduling
Company Announcements

Flora Growth Hails DEA’s Cannabis Rescheduling

Flora Growth Corp. (FLGC) has released an update.

Don't Miss our Black Friday Offers:

Flora Growth Corp., a global leader in consumer-packaged goods and pharmaceutical distribution, celebrates the DEA’s potential decision to downgrade cannabis to Schedule III, signifying lower abuse potential and recognized medical use. This move aligns with the company’s market presence in the U.S. and Germany, both prominent players in the burgeoning legal cannabis sector. Flora Growth’s CEO, Clifford Starke, expresses support for the change, anticipating increased accessibility and ongoing positive momentum for the cannabis industry.

For further insights into FLGC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyFlora Growth initiated with a Buy at Aegis
TipRanks Auto-Generated NewsdeskFlora Growth Corp. Reports Financial Challenges Amid Strategic Shifts
TheFlyFlora Growth price target lowered to $4 from $5 at Roth MKM
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App